Harvest One Announces Receipt of New Cultivation Licence

VANCOUVEROct. 7, 2019 /CNW/ – Harvest One Cannabis Inc. (“Harvest One” or the “Company“) (TSX-V: HVT; OTCQX: HRVOF), through its wholly-owned subsidiary and licensed producer United Greeneries Ltd. (“United Greeneries”), has received a cultivation licence from Health Canada for Phase I of its new Mission Road facility.

The licence allows United Greeneries to immediately begin to cultivate cannabis in the new Mission Road facility located adjacent to the existing facility on Vancouver Island in the town of Duncan, British Columbia. Once fully completed, the Mission Road facility will triple the production capacity in Duncan and increase operational efficiency.

“The issuing of this new licence from Health Canada represents another key accomplishment for Harvest One as we continue to execute on our projects and plans to be a leading producer of premium indoor-grown cannabis,” said Grant Froese, Chief Executive Officer of Harvest One. “With our unique genetics and small batch production under the watchful eye of our first in class cultivation team, we continue to produce top tier cannabis for our discerning consumers.”

Harvest One, through United Greeneries, currently offers its premium cannabis products in four provinces for adult use consumption under the Royal High and Captain’s Choice brands. This premium cannabis is also available to medical patients direct from the United Greeneries site and through Shoppers Drug Mart under the Satipharm brand. The increased supply can also facilitate entry into additional markets for Harvest One’s brands.

About Harvest One

Harvest One is a global cannabis company that develops and provides innovative health, wellness, and selfcare products to consumers and patients in regulated markets around the world. The Company’s range of solutions is designed to enhance quality of life. Shareholders have significant exposure to the entire cannabis value chain through four wholly-owned subsidiaries: United Greeneries, a licensed producer; Satipharm (medical and nutraceutical); and Dream Water Global and Delivra (CPG), and a minority interest in Burb Cannabis (retail operations). For more information, please visit www.harvestone.com.

Cautionary Note Regarding Forward-Looking Statements

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. The forward-looking information contained in this press release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.

SOURCE NEWSWIRE

Leave a Reply

avatar
  Subscribe  
Notify of